News & Media

International certification adds to Quality Management Systems credentials for the medical device industry and supports expansion plans into North America and Asia Pacific regions.

NEW YORK, Sept. 21, 2023 -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful debut of its Intelligent Fingerprinting Drug Screening System at the 2023 Workplace Health & Safety Show in Sydney, Australia on September 20th and 21st.

New assays for ketamine and tramadol testing pass initial Intelligent Fingerprinting design phase and begin next stage of transfer to manufacture.

Since the Company’s entry into the Australian market with its Intelligent Fingerprinting Drug Screening System, the dedicated efforts of the sales force have resulted in the addition of 8 new customers across the Mining, Aviation, Construction, Manufacturing, and Agriculture industries.

Palletways is using the fingerprint drug test, which uses sweat to determine if employees have recently ingested illicit drugs that could affect their fitness to work, as part of its employee induction process.

IBS Inc. has signed a distribution agreement for its Intelligent Fingerprinting Drug Screening System with Chile-based company TSCOM SPA, increasing the product’s availability across South America.

IBS Inc. has received guidance from the U.S. Food and Drug Administration regarding the regulatory classification of its Intelligent Fingerprinting Drug Screening Cartridge.

Lab-testing pathway to expand capabilities of proprietary drug test screening to detect potent opioid fentanyl and fentanyl-adulterated street drugs.